COMPARISON OF HBA1C LEVELS IN DIABETIC PATIENTS TAKING ORAL DRUGS AND INSULIN

Main Article Content

Hammad Hussain Anjum
Raja Hamza Ishtiaq
Najji ullah Malik
Burhan Ahmed
Shajar Naqvi
Zobia Aslam
Aleena Ramzan
Dua Zhaira

Keywords

Abstract

Abstract


Effective management of HbA1c is essential for the well-being of patients with diabetes mellitus. Our study aimed to compare the effect of medication and insulin therapy in controlling blood sugar levels, as measured by HbA1c, in patients with diabetes mellitus. Data collected from 200 patients with diabetes mellitus, was divided into two groups based on their treatment method: medication. Statistical analysis was performed using SPSS software to compare the treatment method and HbA1c levels, as well as the correlation between HbA1c levels and blood sugar levels measured randomly. Our study found that both medication and insulin therapy were ineffective in controlling blood sugar levels. However oral drugs significantly lowered the HbA1c levels in comparison to insulin. Also, there was a positive correlation between HbA1c levels and blood sugar levels measured randomly, indicating the importance of regular monitoring of HbA1c levels in patients with diabetes mellitus. Our study provides valuable perceptions about the management of diabetes mellitus and highlights the importance of personalized treatment approaches that adapt to individual patient characteristics and preferences. Further research with larger sample sizes and more comprehensive study designs is needed to validate these findings and improve outcomes for patients with diabetes mellitus.

Abstract 159 | Pdf Downloads 16

References

1. BAHENDEKA, S., KAUSHIK, R., SWAI, A. B., OTIENO, F., BAJAJ, S., KALRA, S., BAVUMA, C. M. & KARIGIRE, C. 2019. EADSG Guidelines: Insulin Storage and Optimisation of Injection Technique in Diabetes Management. Diabetes Therapy, 10, 341-366.
2. BALLAV, C. & GOUGH, S. C. 2013. Safety and efficacy of sitagliptin-metformin in fixed combination for the treatment of type 2 diabetes mellitus. Clin Med Insights Endocrinol Diabetes, 6, 25-37.
3. CHENG, C.-N., WANG, C.-Y., LIN, H.-W., CHANG, T.-Y., LIN, H.-J., CHOU, C. & LIN, F.-J. 2020. Clinical outcomes of basal insulin and oral antidiabetic agents as an add-on to dual therapy in patients with type 2 diabetes mellitus. Scientific Reports, 10, 5746.
4. CRAMER, J. A. & PUGH, M. J. 2005. The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes care, 28, 78-83.
5. GIUGLIANO, D., MAIORINO, M., BELLASTELLA, G., CHIODINI, P. & ESPOSITO, K. 2011. Relationship of baseline HbA1c, HbA1c change and HbA1c target of< 7% with insulin analogues in type 2 diabetes: a meta‐analysis of randomised controlled trials. International Journal of Clinical Practice, 65, 602-612.
6. GOMES, M. B., RATHMANN, W., CHARBONNEL, B., KHUNTI, K., KOSIBOROD, M., NICOLUCCI, A., POCOCK, S. J., SHESTAKOVA, M. V., SHIMOMURA, I. & TANG, F. 2019. Treatment of type 2 diabetes mellitus worldwide: baseline patient characteristics in the global DISCOVER study. Diabetes research and clinical practice, 151, 20-32.
7. HARAHAP, A. & NASUTION, M. Comparison quality of life patients treated with insulin and oral hypoglycemic drugs. IOP Conference Series: Earth and Environmental Science, 2018. IOP Publishing, 012166.
8. HERNÁNDEZ-ÁVILA, M., GUTIÉRREZ, J. P. & REYNOSO-NOVERÓN, N. 2013. [Diabetes mellitus in Mexico. Status of the epidemic]. Salud Publica Mex, 55 Suppl 2, S129-36.
9. KAZMI, N. H. S., GILLANI, S., AFZAL, S. & HUSSAIN, S. 2013. Correlation between glycated haemoglobin levels and random blood glucose. Journal of Ayub Medical College Abbottabad, 25, 86-88.
10. LINGVAY, I., LEGENDRE, J. L., KALOYANOVA, P. F., ZHANG, S., ADAMS-HUET, B. & RASKIN, P. 2009. Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better? Diabetes care, 32, 1789-1795.
11. NASIR HUSSAIN SHAH, K., SAIMA, G., SALEEM, A. & SAAD, H. 2013. Correlation between glycated haemoglobin levels and random blood glucose.
12. NITIN, S. 2010. HbA1c and factors other than diabetes mellitus affecting it. Singapore Med J, 51, 616-622.
13. PETERSMANN, A., MÜLLER-WIELAND, D., MÜLLER, U. A., LANDGRAF, R., NAUCK, M., FRECKMANN, G., HEINEMANN, L. & SCHLEICHER, E. 2019. Definition, classification and diagnosis of diabetes mellitus. Experimental and Clinical Endocrinology & Diabetes, 127, S1-S7.
14. RIDDLE, M. C. 2008. Combined therapy with insulin plus oral agents: is there any advantage? An argument in favor. Diabetes care, 31, S125-S130.
15. SAEED, A., LAMBOJON, K., SAEED, H., SALEEM, Z., ANWER, N., AZIZ, M. M., JI, W., LIU, W., CHEN, C., YANG, C., FANG, Y. & BABAR, Z. U. 2022. Access to Insulin Products in Pakistan: A National Scale Cross-Sectional Survey on Prices, Availability, and Affordability. Front Pharmacol, 13, 820621.
16. SURYASA, I. W., RODRÍGUEZ-GÁMEZ, M. & KOLDORIS, T. 2021. Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5.
17. VAUGHAN, E. M., MORENO, J. P., HYMAN, D., CHEN, T. A. & FOREYT, J. P. 2017. Efficacy of oral versus insulin therapy for newly diagnosed diabetes in low-income settings. Arch Gen Intern Med, 1, 17-22.
18. ZHAO, R., LU, Z., YANG, J., ZHANG, L., LI, Y. & ZHANG, X. 2020. Drug Delivery System in the Treatment of Diabetes Mellitus. Frontiers in Bioengineering and Biotechnology, 8.

Most read articles by the same author(s)